| Mrs Kyla Christin Jo Cowen, APRN | |
|
3460 E Frank Phillips Blvd, Bartlesville, OK 74006-2406 | |
| (918) 332-3600 | |
| (918) 332-3613 |
| Full Name | Mrs Kyla Christin Jo Cowen |
|---|---|
| Gender | Female |
| Speciality | Nurse Practitioner |
| Experience | 9 Years |
| Location | 3460 E Frank Phillips Blvd, Bartlesville, Oklahoma |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1124497573 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 363LF0000X | Nurse Practitioner - Family | 106977 (Oklahoma) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Jane Phillips Memorial Medical Center, Inc | Bartlesville, OK | Hospital |
| Cherokee Nation W W Hastings Indian Hospital | Tahlequah, OK | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| St John Physicians Inc | 2567366495 | 223 |
News Archive
U.S. President George Bush is about to reveal his plans to fight a flu pandemic and apparently he will ask Congress for funding for a vaccine against bird flu as well as infrastructure to deal with any pandemic.
ThromboGenics NV, a biopharmaceutical company focused on the discovery and development of innovative treatments for eye disease, vascular disease and cancer, announces that its first Phase III trial with microplasmin for the non-surgical treatment of eye disease has met its primary endpoint>Europe, is due to report in the third quarter of 2010.
Meda has completed the acquisition of Alaven and has taken over its operations. The acquisition will benefit Meda both short term and long term. The acquisition will add the therapeutic focus to include both gastroenterology and women's health; areas that Meda operates in outside of the US. In addition, Alaven has a strategic OTC platform that accounts for approximately 25% of sales. Alaven will further diversify Meda's revenue base in the US, as well as serve as a platform for commercializing strategic pipeline opportunities.
Vision scientists long have thought that lack of very long chain fatty acids in photoreceptor cells caused blindness in children with Stargardt type 3 retinal degeneration, an incurable eye disease. But researchers at the University of Utah's John A. Moran Eye Center have shown in a new study that lack of these fatty acids does not cause blindness, meaning that the search for the mechanism that robs sight from children with the disease must start anew.
› Verified 1 days ago
| Entity Name | St John Physicians Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1336194406 PECOS PAC ID: 2567366495 Enrollment ID: O20031121000867 |
News Archive
U.S. President George Bush is about to reveal his plans to fight a flu pandemic and apparently he will ask Congress for funding for a vaccine against bird flu as well as infrastructure to deal with any pandemic.
ThromboGenics NV, a biopharmaceutical company focused on the discovery and development of innovative treatments for eye disease, vascular disease and cancer, announces that its first Phase III trial with microplasmin for the non-surgical treatment of eye disease has met its primary endpoint>Europe, is due to report in the third quarter of 2010.
Meda has completed the acquisition of Alaven and has taken over its operations. The acquisition will benefit Meda both short term and long term. The acquisition will add the therapeutic focus to include both gastroenterology and women's health; areas that Meda operates in outside of the US. In addition, Alaven has a strategic OTC platform that accounts for approximately 25% of sales. Alaven will further diversify Meda's revenue base in the US, as well as serve as a platform for commercializing strategic pipeline opportunities.
Vision scientists long have thought that lack of very long chain fatty acids in photoreceptor cells caused blindness in children with Stargardt type 3 retinal degeneration, an incurable eye disease. But researchers at the University of Utah's John A. Moran Eye Center have shown in a new study that lack of these fatty acids does not cause blindness, meaning that the search for the mechanism that robs sight from children with the disease must start anew.
› Verified 1 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Mrs Kyla Christin Jo Cowen, APRN 3460 E Frank Phillips Blvd, Bartlesville, OK 74006 Ph: (918) 332-3600 | Mrs Kyla Christin Jo Cowen, APRN 3460 E Frank Phillips Blvd, Bartlesville, OK 74006-2406 Ph: (918) 332-3600 |
News Archive
U.S. President George Bush is about to reveal his plans to fight a flu pandemic and apparently he will ask Congress for funding for a vaccine against bird flu as well as infrastructure to deal with any pandemic.
ThromboGenics NV, a biopharmaceutical company focused on the discovery and development of innovative treatments for eye disease, vascular disease and cancer, announces that its first Phase III trial with microplasmin for the non-surgical treatment of eye disease has met its primary endpoint>Europe, is due to report in the third quarter of 2010.
Meda has completed the acquisition of Alaven and has taken over its operations. The acquisition will benefit Meda both short term and long term. The acquisition will add the therapeutic focus to include both gastroenterology and women's health; areas that Meda operates in outside of the US. In addition, Alaven has a strategic OTC platform that accounts for approximately 25% of sales. Alaven will further diversify Meda's revenue base in the US, as well as serve as a platform for commercializing strategic pipeline opportunities.
Vision scientists long have thought that lack of very long chain fatty acids in photoreceptor cells caused blindness in children with Stargardt type 3 retinal degeneration, an incurable eye disease. But researchers at the University of Utah's John A. Moran Eye Center have shown in a new study that lack of these fatty acids does not cause blindness, meaning that the search for the mechanism that robs sight from children with the disease must start anew.
› Verified 1 days ago
Katherine Marie Anderson, CNP Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 3500 Sw Frank Phillips, Bartlesville, OK 74006 Phone: 918-766-1699 | |
Kathryn Marlow, APRN Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 3460 E Frank Phillips Blvd, Bartlesville, OK 74006 Phone: 918-332-3600 | |
Mrs. Priscella Ann Caron, DNP, APRN, FNP-C Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 226 Se De Bell Ave Building B, Bartlesville, OK 74006 Phone: 918-331-1020 | |
Tonya Nicole Henderson, APRN Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 3450 E Frank Phillips Blvd Ste 300, Bartlesville, OK 74006 Phone: 918-331-2273 Fax: 918-338-3761 | |
Mrs. Hester Inez Ferguson, CNP Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 414 E 4th St, Bartlesville, OK 74003 Phone: 918-536-1024 Fax: 918-536-4003 | |
Ana Marshall, Nurse Practitioner Medicare: Not Enrolled in Medicare Practice Location: 400 Se Frank Phillips Blvd, Bartlesville, OK 74003 Phone: 918-333-3136 |